Editorial: metabolic and bariatric surgery: current situation and future challenges

References

[1] Basa ML,Mitchell DP.Metabolic bariatric surgery, alcohol misuse and liver cirrhosis: a narrative review.Metab Target Organ Damage2024;4:29

[2] Chung Y,Jeon D.Obesity, kidney and metabolic bariatric surgery: a surgeon’s narrative review.Metab Target Organ Damage2024;4:38

[3] Em ST,Orandi BJ.Bariatric surgery in patients with obesity and end-stage heart failure with left ventricular assist devices: a brief guide.Metab Target Organ Damage2024;4:39

[4] Péres A,Tibolla V.Evaluation of weight loss and quality of life in long-term post-bariatric surgery.Metab Target Organ Damage2024;4:26

[5] Huele AV,Mcglennon TW.Primary banded RYGB, banded long-limb RYGB, and revisional B-RYGB: weight loss and complications at one-year follow-up.Metab Target Organ Damage2024;4:12

[6] Baldwin D,Altieri MS.Marginal ulceration after Roux-en-Y gastric bypass - literature review and management algorithm.Metab Target Organ Damage2024;4:6

[7] Harrington S,Telesca L,Roux CWL.Long-term complications of significant weight loss: lessons learned from bariatric surgery.Metab Target Organ Damage2023;4:11

[8] Pantelis AG.Standardizing outcomes in metabolic bariatric surgery - more than meets the eye, less than counts the scale.Metab Target Organ Damage2023;4:8

[9] Pantelis AG.Metabolic bariatric surgery in face of new anti-obesity medications-10 + 1 challenges.Metab Target Organ Damage2023;3:17